A genome-wide association study for late-onset Alzheimer's disease using DNA pooling
暂无分享,去创建一个
Sven Cichon | Rebecca Sims | Michael J Owen | Paul Hollingworth | George Kirov | S. Cichon | G. Kirov | M. Owen | V. Moskvina | R. Abraham | P. Hollingworth | R. Sims | K. Dowzell | A. Morgan | Julie Williams | A. Hillmer | M. O’Donovan | L. Georgieva | Julie Williams | Richard Abraham | Valentina Moskvina | Angharad Morgan | Lyudmila Georgieva | Kimberley Dowzell | Axel M Hillmer | Michael C O'Donovan
[1] M C O'Donovan,et al. A genome-wide association study in 574 schizophrenia trios using DNA pooling , 2009, Molecular Psychiatry.
[2] P. Visscher,et al. Highly cost-efficient genome-wide association studies using DNA pools and dense SNP arrays , 2008, Nucleic acids research.
[3] A. J. Slater,et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.
[4] S. Lovestone,et al. Diagnosing Alzheimer's disease—non‐clinicians and computerised algorithms together are as accurate as the best clinical practice , 2007, International journal of geriatric psychiatry.
[5] M. Gill,et al. Association studies of 23 positional/functional candidate genes on chromosome 10 in late‐onset Alzheimer's disease , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[6] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[7] Pauline C Ng,et al. Power to Detect Risk Alleles Using Genome-Wide Tag SNP Panels , 2007, PLoS genetics.
[8] Robert Plomin,et al. Applicability of DNA pools on 500 K SNP microarrays for cost-effective initial screens in genomewide association studies , 2007, BMC Genomics.
[9] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[10] Rebecca F. Halperin,et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.
[11] Stuart Macgregor,et al. Most pooling variation in array-based DNA pooling is attributable to array error rather than pool construction error , 2007, European Journal of Human Genetics.
[12] Rebecca F. Halperin,et al. Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. , 2007, American journal of human genetics.
[13] A. Goodman. Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease , 2006, Journal of cellular physiology.
[14] L. Fratiglioni,et al. Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.
[15] C. Mathers,et al. Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.
[16] G. Kirov,et al. BMC Genomics BioMed Central Methodology article Pooled DNA genotyping on Affymetrix SNP genotyping arrays , 2006 .
[17] D. Clayton,et al. Genome-wide association studies: theoretical and practical concerns , 2005, Nature Reviews Genetics.
[18] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[19] P. So,et al. Disruption of the retinoid signalling pathway causes a deposition of amyloid β in the adult rat brain , 2004, The European journal of neuroscience.
[20] P. McKeigue,et al. Problems of reporting genetic associations with complex outcomes , 2003, The Lancet.
[21] A. Pardee,et al. Evidence for defective retinoid transport and function in late onset Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. O’Donovan,et al. DNA Pooling: a tool for large-scale association studies , 2002, Nature Reviews Genetics.
[23] G. Kirov,et al. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools , 2002, Human Genetics.
[24] L. Cardon,et al. Association study designs for complex diseases , 2001, Nature Reviews Genetics.
[25] Michael Owen,et al. Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools , 2000, Human Genetics.
[26] N. Risch. Searching for genetic determinants in the new millennium , 2000, Nature.
[27] E M Wijsman,et al. The number of trait loci in late-onset Alzheimer disease. , 2000, American journal of human genetics.
[28] P. Lantos,et al. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies , 1999, British Journal of Psychiatry.
[29] R. Bucks,et al. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. , 1996, Age and ageing.
[30] J. Haines,et al. Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives , 1995, Annals of neurology.
[31] M. Pericak-Vance,et al. Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases , 1993, The Lancet.
[32] G. Alexopoulos,et al. Cornell scale for depression in dementia , 1988, Biological Psychiatry.
[33] B. Reisberg,et al. Global Deterioration Scale (GDS). , 1988, Psychopharmacology bulletin.
[34] F. Huppert,et al. CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.
[35] J. Yesavage,et al. A knowledge assessment test for geriatric psychiatry. , 1985, Hospital & community psychiatry.
[36] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[37] M. Roth,et al. The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.
[38] Webster Dd,et al. Critical analysis of the disability in Parkinson's disease. , 1968 .
[39] D. Webster. Critical analysis of the disability in Parkinson's disease. , 1968, Modern treatment.